Related references
Note: Only part of the references are listed.Sclerostin antibody improves phosphate metabolism hormones, bone formation rates, and bone mass in adult Hyp mice
Kelsey A. Carpenter et al.
BONE (2022)
Drug discovery of sclerostin inhibitors
Sifan Yu et al.
Acta Pharmaceutica Sinica B (2022)
Low Levels of Serum Sclerostin in Adult Patients With Tumor-Induced Osteomalacia Compared With X-linked Hypophosphatemia
Xiaolin Ni et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Clinical and genetic analysis in 185 Chinese probands of osteogenesis imperfecta
Lei Xi et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2021)
Clinical and Genetic Characteristics of 153 Chinese Patients With X-Linked Hypophosphatemia
Xiaoyun Lin et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice
Mickael Cardinal et al.
CALCIFIED TISSUE INTERNATIONAL (2020)
Sclerostin Antibody Treatment Increases Bone Mass and Normalizes Circulating Phosphate Levels in Growing Hyp Mice
Kelsey A. Carpenter et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Sclerostin and Its Associations With Bone Metabolism Markers and Sex Hormones in Healthy Community-Dwelling Elderly Individuals and Adolescents
Yang Xu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Osteogenesis imperfecta: an update on clinical features and therapies
Ronit Marom et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Bisphosphonates in the management of Paget's disease
Stuart H. Ralston
BONE (2020)
Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases
Stephanie Fabre et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Elevated Bone Remodeling Markers of CTX and P1NP in Addition to Sclerostin in Patients with X-linked Hypophosphatemia: A Cross-Sectional Controlled Study
Stinus Hansen et al.
CALCIFIED TISSUE INTERNATIONAL (2019)
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
Dieter Haffner et al.
NATURE REVIEWS NEPHROLOGY (2019)
Sclerostin antibody reduces long bone fractures in the oim/oim model of, Check for osteogenesis imperfecta
Mickael Cardinal et al.
BONE (2019)
Evaluation of Bone Metabolism Biomarkers in Paget's Disease of Bone
Glaucio R. Werner de Castro et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2019)
Serum Sclerostin Levels in Adults With Osteogenesis Imperfecta: Comparison With Normal Individuals and Response to Teriparatide Therapy
Lindsey Nicol et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Paget's disease of bone
Natasha M. Appelman-Dijkstra et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models
Aimy Sebastian et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Paget's disease of bone
Tim Cundy
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial
Francis H. Glorieux et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone
Luca Idolazzi et al.
CLINICAL RHEUMATOLOGY (2017)
Hormonal and systemic regulation of sclerostin
Matthew T. Drake et al.
BONE (2017)
Role and mechanism of action of sclerostin in bone
Jesus Delgado-Calle et al.
BONE (2017)
Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α
G. Brunetti et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Circulating Sclerostin in Children and Young Adults with Heritable Bone Disorders
Telma Palomo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Serum Sclerostin Levels Are Decreased in Adult Patients With Different Types of Osteogenesis Imperfecta
Roland Kocijan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Associations of Serum Sclerostin and Polymorphisms in the SOST Gene With Bone Mineral Density and Markers of Bone Metabolism in Postmenopausal Chinese Women
Jinwei He et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Cortical and Trabecular Bone Density in X-Linked Hypophosphatemic Rickets
Moira Cheung et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Circulating Sclerostin Levels and Markers of Bone Turnover in Chinese-American and White Women
Aline G. Costa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Establishing Reference Intervals for Bone Turnover Markers in the Healthy Shanghai Population and the Relationship with Bone Mineral Density in Postmenopausal Women
Wei-Wei Hu et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2013)
Serum sclerostin levels in Paget's disease and prostate cancer with bone metastases with a wide range of bone turnover
Maria P. Yavropoulou et al.
BONE (2012)
Sclerostin levels during growth in children
S. Kirmani et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Sclerostin Is a Locally Acting Regulator of Late-Osteoblast/Preosteocyte Differentiation and Regulates Mineralization Through a MEPE-ASARM-Dependent Mechanism
Gerald J. Atkins et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
Asiri R. Wijenayaka et al.
PLOS ONE (2011)
Increased Sclerostin Serum Levels Associated with Bone Formation and Resorption Markers in Patients with Immobilization-Induced Bone Loss
Agostino Gaudio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Share Paper
